Form 8-A12B - Registration of securities [Section 12(b)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

ZHONG YUAN BIO-TECHNOLOGY

HOLDINGS LIMITED

(Exact name of registrant as specified in its charter)

 

	Cayman Islands			Not Applicable
(State of incorporation or organization)			(I.R.S. Employer
			Identification No.)

 

Suite 901, Tesbury Centre 28 Queen’s Road East Wanchai, Hong Kong
(Address of principal executive offices)		(Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class		Name of each exchange on which
To be so registered		each class is to be registered
Ordinary Shares, $0.001 par value		The Nasdaq Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. o

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. o

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-268025 (if applicable)

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

 

A description of the ordinary shares, par value $0.001 per share, of Zhong Yuan Bio-Technology Holdings Limited (the “Registrant”) being registered hereunder is set forth under the caption “Description of Share Capital” in the prospectus that constitutes a part of the Registrant’s Registration Statement on Form F-1, File No. 333-268025 (the “Registration Statement”), initially filed with the U.S. Securities and Exchange Commission on October 27, 2022, as subsequently amended by any amendments to such Registration Statement and by any form of prospectus filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, in connection with such Registration Statement. Such description is hereby incorporated herein by reference.

 

Item 2. Exhibits.

 

No exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

	ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED
Date: October 26, 2023	By:	/s/ Ting Ting Chang
	Name:	Ting Ting Chang
	Title:	President, Chief Executive Officer, Secretary and Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---